HEMOSTATIC SPRAY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Hemostatic Spray Market, By Product Type (Gelatin Based, Collagen Based, Cellulose Based, Chitosan Based, Combination Hemostats, and Others), By Application (Trauma Care, General Surgery, Vascular Surgery, Cardiac Surgery, Plastic Surgery, Orthopedic Surgery, and Neurosurgery), By End User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments:

New product launches/approval:

In September 2022, Medtronic a medical device company, announced that the company received U.S. Food and Drug Administration (FDA) approval for its powder-to-gel bloodstopping spray for upper gastrointestinal bleeding.
In February 2021, EndoClot Plus, Inc., a medical device company, announced the U.S. Food and Drug Administration (FDA) approval of EndoClot Polysaccharide Hemostatic System (EndoClot PHS), an innovative product that assists Gastroenterologists to stop bleeding rapidly and reliably.

Acquisition and partnerships:

In October 2022, Teleflex acquired Z-Medica to enhance its product portfolio with innovative hemostatic technologies for surgical applications.
On May 16, 2023, Olympus Corporation, a medical device company, announced partnering with EndoClot Plus, Inc., a medical device company, to launch hemostatic agents in Europe, Middle East and Africa region.

Hemostatic Spray Market Report Snapshots